← Back to Search

Behavioral Intervention

Personalized OSA messages for Obstructive Sleep Apnea

N/A
Waitlist Available
Led By Rebecca Robbins, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the sofhl will be administered at baseline and post-intervention. change in sofhl score on osa general knowledge will be computed by comparing responses at baseline and post-intervention.
Awards & highlights

Study Summary

This trial will use focus groups to learn about employees' beliefs, attitudes, and knowledge about obstructive sleep apnea (OSA) among people who work on shift schedules.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the sofhl will be administered at baseline and post-intervention. change in sofhl score on self-management efficacy will be computed by comparing responses at baseline and post-intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the sofhl will be administered at baseline and post-intervention. change in sofhl score on self-management efficacy will be computed by comparing responses at baseline and post-intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in OSA self-management efficacy as measured by the Survey of OSA Functional Health Literacy (SOFHL)
Secondary outcome measures
Change in Attentional Failures as measured by previously validated questions assessing Attentional Failures.
Change in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS).
Change in OSA general knowledge as measured by the SOFHL.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
Participants will receive the personalized OSA messages.
Group II: ControlPlacebo Group1 Intervention
Placebo participants will receive no treatment during the experiment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Personalized OSA messages
2022
N/A
~40

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,834 Previous Clinical Trials
47,310,597 Total Patients Enrolled
Brigham and Women's HospitalLead Sponsor
1,609 Previous Clinical Trials
11,470,289 Total Patients Enrolled
Rebecca Robbins, PhDPrincipal InvestigatorBrigham and Women's Hospital
1 Previous Clinical Trials
1,355 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What potential benefits does this clinical study seek to bring about?

"The primary goal of this trial, measured over a given time frame, is to evaluate change in OSA self-management efficacy as captured by the Survey of OSA Functional Health Literacy (SOFHL). Secondary objectives include assessing changes in daytime sleepiness with the Epworth Sleepiness Scale (ESS), appraising attentional failures via self-reported questions, and measuring levels of general knowledge related to OSA using SOFHL. Baseline SEMSA scores will be compared against post-intervention responses."

Answered by AI

Are there currently opportunities for participants to join this experiment?

"As per the information listed on clinicaltrials.gov, this trial is not recruiting patients at present. The study was initially published on October 1st 2022 and last modified 7th July 2022. Although there are no active recruitment opportunities for this experiment right now, 403 other trials require participants immediately."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

1. I like to contribute to science. 2. I despise having sleep apnea.
PatientReceived no prior treatments
~15 spots leftby Apr 2025